Registration for on-demand access open through October 7. Evaluations due October 14.
ONS Bridge™
Improved Staff Access to Gold Standard Evidence-Based Education.
ONS On-Demand™
The Fundamental Oncology Nursing Course, Cancer Basics, is Now Available in Spanish.
Cancer Basics (Spanish Version)
Your donation will make a difference.
Give to the Oncology Nursing Foundation
Get our fact sheet, manage PPE supplies, and learn about implications for patients with cancer.
ONS Information Regarding the Coronavirus (COVID-19)
ONS Center for Innovation Launches New Tool to Help Improve Patient Outcomes
ONS On-Call™We are students, clinicians, scientists, educators, and mentors working together to transform the way the world cares for cancer.
On September 20, 2021, the U.S. Food and Drug Administration (FDA) granted accelerated approval to tisotumab vedotin-tftv (Tivdak™), a tissue factor-directed antibody and microtubule inhibitor conjugate, for adult patients with recurrent or metastatic cervical cancer whose disease has progressed on or after chemotherapy.
